-
1
-
-
84890939875
-
Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals
-
Holme O, Bretthauer M, Fretheim A, Odgaard-Jensen J, Hoff G. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev 2013; 9: CD009259.
-
(2013)
Cochrane Database Syst Rev
, vol.9
, pp. CD009259
-
-
Holme, O.1
Bretthauer, M.2
Fretheim, A.3
Odgaard-Jensen, J.4
Hoff, G.5
-
2
-
-
84885136577
-
Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews
-
Sutcliffe P, Connock M, Gurung T, et al. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews. Health Technol Assess 2013; 17: 1–253.
-
(2013)
Health Technol Assess
, vol.17
, pp. 1-253
-
-
Sutcliffe, P.1
Connock, M.2
Gurung, T.3
-
3
-
-
84863726621
-
Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis
-
Hassan C, Rex DK, Cooper GS, Zullo A, Launois R, Benamouzig R. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis. Gut 2011; 61: 1172–9.
-
(2011)
Gut
, vol.61
, pp. 1172-1179
-
-
Hassan, C.1
Rex, D.K.2
Cooper, G.S.3
Zullo, A.4
Launois, R.5
Benamouzig, R.6
-
5
-
-
68049122102
-
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
-
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
-
(2009)
PLoS Med
, vol.6
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
Altman, D.G.4
-
6
-
-
84932084410
-
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations
-
Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 2015; 162: 777–84.
-
(2015)
Ann Intern Med
, vol.162
, pp. 777-784
-
-
Hutton, B.1
Salanti, G.2
Caldwell, D.M.3
-
7
-
-
78650215449
-
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
-
Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010; 376: 1741–50.
-
(2010)
Lancet
, vol.376
, pp. 1741-1750
-
-
Rothwell, P.M.1
Wilson, M.2
Elwin, C.E.3
-
8
-
-
42949127635
-
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
-
Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570–95.
-
(2008)
Gastroenterology
, vol.134
, pp. 1570-1595
-
-
Levin, B.1
Lieberman, D.A.2
McFarland, B.3
-
9
-
-
0026355123
-
The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results
-
Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991; 54: 1044–54.
-
(1991)
J Neurol Neurosurg Psychiatry
, vol.54
, pp. 1044-1054
-
-
Farrell, B.1
Godwin, J.2
Richards, S.3
Warlow, C.4
-
10
-
-
0032562005
-
Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework
-
Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet 1998; 351: 233–41.
-
(1998)
Lancet
, vol.351
, pp. 233-241
-
-
-
11
-
-
0023845856
-
Randomised trial of prophylactic daily aspirin in British male doctors
-
Peto R, Gray R, Collins R, et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 1988; 296: 313–6.
-
(1988)
Br Med J (Clin Res Ed)
, vol.296
, pp. 313-316
-
-
Peto, R.1
Gray, R.2
Collins, R.3
-
12
-
-
0025751563
-
Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group
-
Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group. Lancet 1991; 338: 1345–9.
-
(1991)
Lancet
, vol.338
, pp. 1345-1349
-
-
-
13
-
-
34248157118
-
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
-
Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007; 369: 1603–13.
-
(2007)
Lancet
, vol.369
, pp. 1603-1613
-
-
Flossmann, E.1
Rothwell, P.M.2
-
14
-
-
0027161914
-
Low-dose aspirin and incidence of colorectal tumors in a randomized trial
-
Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 1993; 85: 1220–4.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 1220-1224
-
-
Gann, P.H.1
Manson, J.E.2
Glynn, R.J.3
Buring, J.E.4
Hennekens, C.H.5
-
15
-
-
84880278340
-
Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial
-
Cook NR, Lee IM, Zhang SM, Moorthy MV, Buring JE. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med 2013; 159: 77–85.
-
(2013)
Ann Intern Med
, vol.159
, pp. 77-85
-
-
Cook, N.R.1
Lee, I.M.2
Zhang, S.M.3
Moorthy, M.V.4
Buring, J.E.5
-
18
-
-
70449517166
-
-
Ottawa, Canadian Agency for Drugs and Technologies in Health
-
Wells GA, Sultan SA, Chen L, Khan M, Coyle D. Indirect Evidence: Indirect Treatment Comparisons in Meta-analysis. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2009.
-
(2009)
Indirect Evidence: Indirect Treatment Comparisons in Meta-analysis
-
-
Wells, G.A.1
Sultan, S.A.2
Chen, L.3
Khan, M.4
Coyle, D.5
-
19
-
-
84884879422
-
Graphical tools for network meta-analysis in STATA
-
[Electronic Resource]
-
Chaimani A, Higgins JPT, Mavridis D, Spyridonos P, Salanti G. Graphical tools for network meta-analysis in STATA. PLoS ONE [Electronic Resource] 2013; 8: e76654.
-
(2013)
PLoS ONE
, vol.8
-
-
Chaimani, A.1
Higgins, J.P.T.2
Mavridis, D.3
Spyridonos, P.4
Salanti, G.5
-
20
-
-
84875612338
-
Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression
-
White IR, Barrett JK, Jackson D, Higgins JP. Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression. Res Synth Methods 2012; 3: 111–25.
-
(2012)
Res Synth Methods
, vol.3
, pp. 111-125
-
-
White, I.R.1
Barrett, J.K.2
Jackson, D.3
Higgins, J.P.4
-
21
-
-
68149160854
-
Multivariate random-effects meta-analysis
-
White IR. Multivariate random-effects meta-analysis. Stata J 2009; 9: 40–56.
-
(2009)
Stata J
, vol.9
, pp. 40-56
-
-
White, I.R.1
-
22
-
-
79960824714
-
Multivariate random-effects meta-regression: Updates to mvmeta
-
White IR. Multivariate random-effects meta-regression: Updates to mvmeta. Stata J 2011; 11: 255–70.
-
(2011)
Stata J
, vol.11
, pp. 255-270
-
-
White, I.R.1
-
24
-
-
84899557077
-
Characteristics of networks of interventions: a description of a database of 186 published networks
-
[Electronic Resource]
-
Nikolakopoulou A, Chaimani A, Veroniki AA, Vasiliadis HS, Schmid CH, Salanti G. Characteristics of networks of interventions: a description of a database of 186 published networks. PLoS ONE [Electronic Resource] 2014; 9: e86754.
-
(2014)
PLoS ONE
, vol.9
-
-
Nikolakopoulou, A.1
Chaimani, A.2
Veroniki, A.A.3
Vasiliadis, H.S.4
Schmid, C.H.5
Salanti, G.6
-
26
-
-
80052676840
-
Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial—SCORE
-
Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial—SCORE. J Natl Cancer Inst 2011; 103: 1310–22.
-
(2011)
J Natl Cancer Inst
, vol.103
, pp. 1310-1322
-
-
Segnan, N.1
Armaroli, P.2
Bonelli, L.3
-
27
-
-
84861573867
-
Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up
-
Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut 2012; 61: 1036–40.
-
(2012)
Gut
, vol.61
, pp. 1036-1040
-
-
Scholefield, J.H.1
Moss, S.M.2
Mangham, C.M.3
Whynes, D.K.4
Hardcastle, J.D.5
-
28
-
-
84862583882
-
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy
-
Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012; 366: 2345–57.
-
(2012)
N Engl J Med
, vol.366
, pp. 2345-2357
-
-
Schoen, R.E.1
Pinsky, P.F.2
Weissfeld, J.L.3
-
29
-
-
84975730903
-
Screening for Colorectal cancer: updated evidence report and systematic review for the US preventive services task force
-
Lin JS, Piper MA, Perdue LA, et al. Screening for Colorectal cancer: updated evidence report and systematic review for the US preventive services task force. JAMA 2016; 315: 2576–94.
-
(2016)
JAMA
, vol.315
, pp. 2576-2594
-
-
Lin, J.S.1
Piper, M.A.2
Perdue, L.A.3
-
30
-
-
85002416216
-
-
Chubak J, Kamineni A, Buist DSM, Anderson ML, Whitlock EP, 2015.
-
(2015)
-
-
Chubak, J.1
Kamineni, A.2
Buist, D.S.M.3
Anderson, M.L.4
Whitlock, E.P.5
-
31
-
-
84941346697
-
Aspirin for primary prevention of cardiovascular disease and cancer. A benefit and harm analysis
-
Stegeman I, Bossuyt PM, Yu T, Boyd C, Puhan MA. Aspirin for primary prevention of cardiovascular disease and cancer. A benefit and harm analysis. PLoS ONE 2015; 10: e0127194.
-
(2015)
PLoS ONE
, vol.10
-
-
Stegeman, I.1
Bossuyt, P.M.2
Yu, T.3
Boyd, C.4
Puhan, M.A.5
-
32
-
-
84922908649
-
Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women
-
Van Kruijsdijk RCM, Visseren FLJ, Ridker PM, et al. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women. Heart 2015; 101: 369–76.
-
(2015)
Heart
, vol.101
, pp. 369-376
-
-
Van Kruijsdijk, R.C.M.1
Visseren, F.L.J.2
Ridker, P.M.3
-
33
-
-
84942597080
-
Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer
-
Puhan MA, Yu T, Stegeman I, Varadhan R, Singh S, Boyd CM. Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer. BMC Med 2015; 13: 250.
-
(2015)
BMC Med
, vol.13
, pp. 250
-
-
Puhan, M.A.1
Yu, T.2
Stegeman, I.3
Varadhan, R.4
Singh, S.5
Boyd, C.M.6
-
34
-
-
84940381575
-
Long-term lifestyle changes after colorectal cancer screening: randomised controlled trial
-
Berstad P, Loberg M, Larsen IK, et al. Long-term lifestyle changes after colorectal cancer screening: randomised controlled trial. Gut 2015; 64: 1268–76.
-
(2015)
Gut
, vol.64
, pp. 1268-1276
-
-
Berstad, P.1
Loberg, M.2
Larsen, I.K.3
-
35
-
-
78650825618
-
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
-
Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011; 377: 31–41.
-
(2011)
Lancet
, vol.377
, pp. 31-41
-
-
Rothwell, P.M.1
Fowkes, F.G.2
Belch, J.F.3
Ogawa, H.4
Warlow, C.P.5
Meade, T.W.6
-
36
-
-
84860467522
-
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
-
Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol 2012; 13: 518–27.
-
(2012)
Lancet Oncol
, vol.13
, pp. 518-527
-
-
Algra, A.M.1
Rothwell, P.M.2
-
37
-
-
85006220619
-
Long-term effectiveness of endoscopic screening on incidence and mortality of colorectal cancer: a randomized trial
-
Thiis-Evensen E, Kalager M, Bretthauer M, Hoff G. Long-term effectiveness of endoscopic screening on incidence and mortality of colorectal cancer: a randomized trial. United European Gastroenterol J 2013; 1: 162–8.
-
(2013)
United European Gastroenterol J
, vol.1
, pp. 162-168
-
-
Thiis-Evensen, E.1
Kalager, M.2
Bretthauer, M.3
Hoff, G.4
-
38
-
-
84905901559
-
Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial
-
Holme O, Loberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA 2014; 312: 606–15.
-
(2014)
JAMA
, vol.312
, pp. 606-615
-
-
Holme, O.1
Loberg, M.2
Kalager, M.3
-
39
-
-
77951879165
-
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial
-
Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375: 1624–33.
-
(2010)
Lancet
, vol.375
, pp. 1624-1633
-
-
Atkin, W.S.1
Edwards, R.2
Kralj-Hans, I.3
-
40
-
-
0034735826
-
The effect of fecal occult-blood screening on the incidence of colorectal cancer
-
Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603–7.
-
(2000)
N Engl J Med
, vol.343
, pp. 1603-1607
-
-
Mandel, J.S.1
Church, T.R.2
Bond, J.H.3
-
41
-
-
84884183059
-
Long-term mortality after screening for colorectal cancer
-
Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med 2013; 369: 1106–14.
-
(2013)
N Engl J Med
, vol.369
, pp. 1106-1114
-
-
Shaukat, A.1
Mongin, S.J.2
Geisser, M.S.3
-
42
-
-
48249127689
-
Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer
-
Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 2008; 95: 1029–36.
-
(2008)
Br J Surg
, vol.95
, pp. 1029-1036
-
-
Lindholm, E.1
Brevinge, H.2
Haglind, E.3
-
43
-
-
4544310710
-
Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds
-
Kronborg O, Jørgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 2004; 39: 846–51.
-
(2004)
Scand J Gastroenterol
, vol.39
, pp. 846-851
-
-
Kronborg, O.1
Jørgensen, O.D.2
Fenger, C.3
Rasmussen, M.4
-
44
-
-
0034014839
-
Baseline characteristics of participants in the Women's Health Study
-
Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med 2000; 9: 19–27.
-
(2000)
J Womens Health Gend Based Med
, vol.9
, pp. 19-27
-
-
Rexrode, K.M.1
Lee, I.M.2
Cook, N.R.3
Hennekens, C.H.4
Buring, J.E.5
-
45
-
-
21444450527
-
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial
-
Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005; 294: 47–55.
-
(2005)
JAMA
, vol.294
, pp. 47-55
-
-
Cook, N.R.1
Lee, I.M.2
Gaziano, J.M.3
-
46
-
-
0024298599
-
Findings from the aspirin component of the ongoing Physicians’ Health Study
-
Findings from the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med 1988; 318: 262–4.
-
(1988)
N Engl J Med
, vol.318
, pp. 262-264
-
-
|